259 related articles for article (PubMed ID: 28427201)
1. Wnt5a / planar cell polarity signaling pathway in urothelial carcinoma, a potential prognostic biomarker.
Saling M; Duckett JK; Ackers I; Coschigano K; Jenkinson S; Malgor R
Oncotarget; 2017 May; 8(19):31655-31665. PubMed ID: 28427201
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Wnt5a expression with histopathological grade/stage in urothelial carcinoma of the bladder.
Malgor R; Crouser S; Greco D; Brockett C; Coschigano K; Nakazawa M; Jenkinson S
Diagn Pathol; 2013 Aug; 8():139. PubMed ID: 23947922
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of WNT5A long and short isoforms in non-muscle-invasive bladder urothelial carcinoma.
Strope AM; Phillips C; Khadgi S; Jenkinson SA; Coschigano KT; Malgor R
Histol Histopathol; 2024 Jun; 39(6):715-727. PubMed ID: 38445662
[TBL] [Abstract][Full Text] [Related]
4. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
Caprodossi S; Lucciarini R; Amantini C; Nabissi M; Canesin G; Ballarini P; Di Spilimbergo A; Cardarelli MA; Servi L; Mammana G; Santoni G
Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M
Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277
[TBL] [Abstract][Full Text] [Related]
6. WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach.
Otto W; Breyer J; Herdegen S; Eder F; Bertz S; May M; Mayr R; Lausenmeyer EM; Denzinger S; van Rhijn BW; Burger M; Hartmann A
Int Urol Nephrol; 2017 Mar; 49(3):431-437. PubMed ID: 28035618
[TBL] [Abstract][Full Text] [Related]
7. Characterization and impact of non-canonical WNT signaling on outcomes of urothelial carcinoma.
Meagher M; Krause H; Elliott A; Farrell A; Antonarakis ES; Bastos B; Heath EI; Jamieson C; Stewart TF; Bagrodia A; Nabhan C; Oberley M; McKay RR; Salmasi A
Cancer Med; 2024 Apr; 13(7):e7148. PubMed ID: 38558536
[TBL] [Abstract][Full Text] [Related]
8. Critical roles of Wnt5a-Ror2 signaling in aggressiveness of tongue squamous cell carcinoma and production of matrix metalloproteinase-2 via ΔNp63β-mediated epithelial-mesenchymal transition.
Sakamoto T; Kawano S; Matsubara R; Goto Y; Jinno T; Maruse Y; Kaneko N; Hashiguchi Y; Hattori T; Tanaka S; Kitamura R; Kiyoshima T; Nakamura S
Oral Oncol; 2017 Jun; 69():15-25. PubMed ID: 28559016
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin overexpression predicts poor prognosis of upper urinary tract urothelial carcinoma.
Ke HL; Chang LL; Yang SF; Lin HH; Li CC; Wu DC; Wu WJ
Urol Oncol; 2011; 29(6):703-9. PubMed ID: 20022267
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
11. Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1.
Rausch S; Hennenlotter J; Teepe K; Kuehs U; Aufderklamm S; Bier S; Mischinger J; Gakis G; Stenzl A; Schwentner C; Todenhöfer T
Urol Oncol; 2015 Oct; 33(10):426.e21-9. PubMed ID: 26231311
[TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of 5hmC in bladder urothelial carcinoma].
Li J; Xu Y; Zhang Z; Zhang M; Zhang Z; Zhang F; Li Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):232-5. PubMed ID: 26927384
[TBL] [Abstract][Full Text] [Related]
13. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
Zhang Z; Zhang G; Kong C
Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
[TBL] [Abstract][Full Text] [Related]
14. Wnt5a and Ror2 expression associate with the disease progress of primary thyroid lymphoma.
Wang L; Yang D; Wang YH; Li X; Gao HM; Lv JY; Wang L; Xin SJ
Tumour Biol; 2016 May; 37(5):6085-90. PubMed ID: 26608372
[TBL] [Abstract][Full Text] [Related]
15. Indoleamine-2,3-dioxygenase-1 expression predicts poorer survival and up-regulates ZEB2 expression in human early stage bladder cancer.
Tsai YS; Jou YC; Tsai HT; Cheong IS; Tzai TS
Urol Oncol; 2019 Nov; 37(11):810.e17-810.e27. PubMed ID: 31253481
[TBL] [Abstract][Full Text] [Related]
16. Urokinase-type plasminogen activator receptor (uPAR) expression is associated with T-stage and survival in urothelial carcinoma of the bladder.
Dohn LH; Illemann M; Høyer-Hansen G; Christensen IJ; Hostmark J; Litlekalsoy J; von der Maase H; Pappot H; Laerum OD
Urol Oncol; 2015 Apr; 33(4):165.e15-24. PubMed ID: 25575713
[TBL] [Abstract][Full Text] [Related]
17. IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
Liang PI; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Wu JY; Li CF
J Clin Pathol; 2013 Jul; 66(7):573-82. PubMed ID: 23539739
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Wnt/planar cell polarity pathway in cultured cells.
Endo M; Nishita M; Minami Y
Methods Mol Biol; 2012; 839():201-14. PubMed ID: 22218903
[TBL] [Abstract][Full Text] [Related]
19. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-374a Inhibits Aggressive Tumor Biological Behavior in Bladder Carcinoma by Suppressing Wnt/β-Catenin Signaling.
Chen X; Jia C; Jia C; Jin X; Gu X
Cell Physiol Biochem; 2018; 48(2):815-826. PubMed ID: 30032142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]